194 related articles for article (PubMed ID: 37124041)
1. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome.
Zaltron S; Cambianica A; Di Gregorio M; Colangelo C; Storti S; Tiecco G; Castelli F; Quiros-Roldan E
Front Cell Infect Microbiol; 2023; 13():1143346. PubMed ID: 37124041
[TBL] [Abstract][Full Text] [Related]
2. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
[TBL] [Abstract][Full Text] [Related]
3. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.
Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V
J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.
Aggeletopoulou I; Konstantakis C; Manolakopoulos S; Triantos C
World J Gastroenterol; 2017 Jun; 23(24):4317-4323. PubMed ID: 28706414
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.
Morsica G; Ancarani F; Bagaglio S; Maracci M; Cicconi P; Cozzi Lepri A; Antonucci G; Bruno R; Santantonio T; Tacconi L; Baldelli F; Piscopo R; Santoro D; Lazzarin A; D'Arminio Monforte A;
Infection; 2009 Oct; 37(5):445-9. PubMed ID: 19669092
[TBL] [Abstract][Full Text] [Related]
7. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
[TBL] [Abstract][Full Text] [Related]
8. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients.
Tseng CW; Liu WC; Ko PH; Chen YC; Tseng KC; Chang TT
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016434
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C.
Toka B; Köksal AŞ; Dertli R; Şirin G; Fidan S; Ülger Y; Harmandar F; Yıldırım AE; Eminler AT; Asil M; Kayar Y; Bıyık M; Kuran S; Uslan MI; Hülagü S
Dig Dis; 2022; 40(5):635-643. PubMed ID: 35108715
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.
Costantini A; Marinelli K; Biagioni G; Monachetti A; Ferreri ML; Butini L; Montroni M; Manzin A; Bagnarelli P
BMC Infect Dis; 2011 Nov; 11():310. PubMed ID: 22054111
[TBL] [Abstract][Full Text] [Related]
12. Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients.
Yoshikawa S; Yoshio S; Yoshida Y; Tsutsui Y; Kawai H; Yamazoe T; Mori T; Osawa Y; Sugiyama M; Iwamoto M; Watashi K; Kawaguchi T; Akita T; Tanaka J; Kikuchi Y; Mizokami M; Oka S; Kanto T; Gatanaga H
J Infect Dis; 2021 Jun; 223(12):2080-2089. PubMed ID: 33073291
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV).
Pisaturo M; Macera M; Alessio L; Calò F; Coppola N
Viruses; 2019 Sep; 11(9):. PubMed ID: 31540223
[TBL] [Abstract][Full Text] [Related]
18. Viral hepatitis in persons living with HIV in the post-COVID era.
Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.
Holmes JA; Yu ML; Chung RT
Expert Opin Drug Saf; 2017 Jun; 16(6):651-672. PubMed ID: 28471314
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B and HIV infection.
Soriano V; Aguilera A; Gonzalez R; Gomez-Gallego F; Barea L; Treviño M; Corral O
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1403-1407. PubMed ID: 30969194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]